Cardiovascular disease remains a leading cause of illness worldwide, and researchers are exploring new ways to support heart and blood vessel function. This mini‑review article looks at the therapeutic potential of cannabigerol (CBG)—a non‑psychoactive cannabinoid from the cannabis plant—with a particular focus on its possible effects on the cardiovascular system. The authors summarize laboratory and […]
Research-Based Information
Cannabidiol (CBD) Shows Promise for Supporting Dogs With Atopic Dermatitis (pub. Feb 2025)
Atopic dermatitis is a chronic inflammatory skin condition common in dogs, often causing persistent itching, redness, and discomfort. In this study, researchers explored whether cannabidiol (CBD)—a non‑psychoactive compound from hemp—might help ease skin symptoms in dogs with atopic dermatitis. Because this condition involves inflammation and immune system activity, scientists looked at CBD’s potential effects on […]
Cannabigerol (CBG): A Broad Look at Its Molecular Actions and Potential Benefits (pub. Nov 2024)
Researchers are increasingly interested in cannabigerol (CBG), a non‑psychoactive cannabinoid found in the cannabis plant, because it interacts with many biological systems in the body that influence health and wellness. This comprehensive review summarizes what scientists currently know about CBG’s molecular mechanisms—how it works at the cellular level—and its therapeutic potential across a range of […]